Press Releases
- FlexFactory platform for oligonucleotides, an integrated solution to boost efficiency and speed of pharmaceutical manufacturing to meet market demand
SHANGHAI, May 10, 2024 /PRNewswire/ -- Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva's first... (continue reading...)
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor... (continue reading...)- 2023 Revenue of $34.8 million; Adjusted EBITDA1 of $5.5 million; EBITDA1 of $16.6 million.
- Generated YTD cash flow from operations of $4.4 million.
- Anticipated launch of adult-use program in Ohio expected to drive significant growth for Vext. On closing of Ohio Expansion Transaction, Vext will have an operating Tier I cultivation facility, an operating manufacturing facility, and four dispensaries in Ohio2.
Vancouver, British Columbia--(Newsfile Corp. - May 10, 2024) - ... (continue reading...)
SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President and Executive Chairman, will be attending the EF Hutton Annual Global Conference, which will be held at The Plaza Hotel in New York, NY on Wednesday, May 15, 2024.
EventEF Hutton Annual Global Conference
DateMay 15, 2024
LocationThe Plaza Hotel, New... (continue reading...)
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 10, 2024 (GLOBE NEWSWIRE) --
Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today revealed significant growth in the CENTOGENE Biodatabank, the world’s largest real-world data repository for rare and neurodegenerative diseases. Analysis of this patient data enables precise diagnosis of disease, identification of new genetic... (continue reading...)
More Press Releases
View Older Stories-
Crescent Point Announces Q1 2024 Results
-
Algonquin Power & Utilities Corp. Announces CEO Update and 2024 First Quarter Financial Results
-
SANUWAVE Announces Q1 FY2024 Financial Results
-
Algonquin Power & Utilities Corp. Declares Second Quarter 2024 Common Share Dividend of U.S.$0.1085 (C$0.1490), and Declares Second Quarter 2024 Preferred Share Dividends
-
LAMONS ANNOUNCES COLLABORATION WITH H2SCAN
-
Ault Alliance’s Subsidiary, Sentinum, Announces 89 Bitcoin Mined in April 2024
-
FTC Solar Announces First Quarter 2024 Financial Results
-
Chart Industries to Participate in Investor Events
-
DOCOMO to Launch "NTT DOCOMO GLOBAL" for Global Expansion
-
Technology Global Solutions offers a revolutionary offer in the trading platform market: Free MetaTrader server installation for Victory Day!
-
NOTICE TO THE ANNUAL GENERAL MEETING
-
Crescent Point Confirms Quarterly Dividend
-
Unleashing the New Momentum for China-Germany (China-Europe) Economic and Technological Cooperation
-
AngloGold Ashanti Delivers Steady Start to 2024; Gold Production¹ Up +2% y-o-y; Gold Production Guidance Reconfirmed and Obuasi on Track to Achieve FY 2024 Forecast Gold Production
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares
-
DeFi Builder Pioneers No-Code Web3 Development with ERC404 Token Builder and AI Smart Contract Generator
-
Mario Lemieux Foundation, Highmark Health Announce Major Gift to AHN Cardiovascular Institute, Establishing "The Mario Lemieux Center for Heart Rhythm Care"
-
Li-Cycle Reports First Quarter 2024 Operational and Financial Results
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRENT COMMUNICATIONS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Redrow plc - Ordinary Shares
-
Costamare Inc. Reports Results for the First Quarter Ended March 31, 2024
-
SANUWAVE Announces Q1 FY2024 Financial Results
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
LKQ Corporation Executes Agreement to Sell Elit Polska in Poland to MEKO AB
-
Minister Ebrahim Patel to Visit Hisense South Africa Factory
-
VerticalScope to Participate in Upcoming Investor Conferences in May and June 2024
-
Mondee Reports First Quarter 2024 Results
-
Flash News: OKX Launches "Space Nation x OKX Exploration Ship NFT Allowlist Giveaway"
-
Bayridge Resources Completes Cash and Share Obligations Towards Initial 40% Earn-In at Its Athabasca Basin Uranium Properties
-
Goodbaby International Holdings Limited Announces First Quarter Revenue Performance
-
Weekly Recap: 13 Press Releases You Might Have Missed
-
Canlan Reports Record Q1 Revenue
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL DISTRIBUTIONS - Ordinary Shares
-
Canaan Inc. to Report First Quarter 2024 Financial Results on May 17, 2024
-
KE Holdings Inc. to Report First Quarter 2024 Financial Results on May 23, 2024 Eastern Time
-
Hello Group to Report First Quarter 2024 Results on May 28, 2024
-
Media advisory: NS Police Officers will Receive Constable Heidi Stevenson’s Watch Award on May 13
-
Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
-
ChipMOS REPORTS APRIL 2024 YEAR-OVER-YEAR REVENUE GROWTH
-
CBAK Energy Reports First Quarter 2024 Unaudited Financial Results
-
Consumers Spend 30% of Monthly Food Budgets on Restaurants, Down from 40% in 2022, Popmenu Study Finds
-
Baozun Schedules Annual General Meeting of Shareholders
-
Pivotree Announces First Quarter 2024 Results
-
Capsida Biotherapeutics to Present Preclinical Data for Parkinson's Disease Associated with GBA Mutations Showing High Levels of GCase Enzyme Supplementation Following IV Administration
-
Defiance Launches USOY, The First Oil Enhanced Options Income ETF.
-
Yalla Group Limited to Report First Quarter 2024 Financial Results on May 20, 2024 Eastern Time
-
Advanced Energy to Participate at Upcoming Investor Conferences
-
American Strategic Investment Co. Announces First Quarter 2024 Results
-
NHC Reports First Quarter 2024 Earnings
-
Affinia Therapeutics Presents Preclinical Data for Genetic Cardiomyopathy and Sporadic ALS Programs with Novel Cardiotropic and BBB-Penetrant AAV Capsids at the American Society of Gene & Cell The